SciSparc announced that MitoCareX Bio has appointed Professor Nir Peled as a member of its scientific advisory board. Professor Peled is a distinguished expert in thoracic oncology, holding board certifications in internal medicine, pulmonology, and medical oncology. His extensive contributions to the field are well-recognized, having served as a board member of the International Association for the Study of Lung Cancer and currently the chair of the Global Multidisciplinary Practice Standards Committee, as well as past Chair of the IASLC’s Screening & Early Detection Committee. Additionally, he recently concluded his term as the Chair of the Thoracic Cancer Assembly of the European Thoracic Society.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRC:
- SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Board
- SciSparc Initiates Groundbreaking Autism Therapy Trial
- SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment
- SciSparc enrolls first five patients in child ASD trial
- SciSparc Ltd. Grants Exclusive License to Polyrizon